stoxline Quote Chart Rank Option Currency Glossary
Femasys Inc. (FEMY)
0.882  -0.011 (-1.21%)    12-07 16:00
Open: 0.9018
High: 0.9018
Volume: 345,744
Pre. Close: 0.8928
Low: 0.872
Market Cap: 19(M)
Technical analysis
2023-12-07 4:20:36 PM
Short term     
Mid term     
Targets 6-month :  1.47 1-year :  1.77
Resists First :  1.26 Second :  1.51
Pivot price 0.94
Supports First :  0.83 Second :  0.69
MAs MA(5) :  0.9 MA(20) :  0.98
MA(100) :  0.91 MA(250) :  0.93
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  12.4 D(3) :  15.6
RSI RSI(14): 38.5
52-week High :  4.75 Low :  0.24
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ FEMY ] has closed above bottom band by 15.0%. Bollinger Bands are 80.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.9 - 0.91 0.91 - 0.91
Low: 0.86 - 0.86 0.86 - 0.87
Close: 0.87 - 0.88 0.88 - 0.89
Company Description

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

Headline News

Wed, 29 Nov 2023
Should You Sell Femasys Inc (FEMY) Stock Wednesday Morning? - InvestorsObserver

Tue, 28 Nov 2023
Femasys: Ready To Turn The Corner (NASDAQ:FEMY) - Seeking Alpha

Tue, 28 Nov 2023
Femasys Inc (FEMY) Up 0.97% in Premarket Trading - InvestorsObserver

Fri, 24 Nov 2023
Should Medical Instruments & Supplies Stock Femasys Inc (FEMY) Be in Your Portfolio Friday? - InvestorsObserver

Thu, 16 Nov 2023
Femasys Inc (FEMY) Down 0.99% in Premarket Trading - InvestorsObserver

Wed, 15 Nov 2023
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical Instruments & Supplies
Shares Out 0 (M)
Shares Float 22 (M)
Held by Insiders 1.941e+007 (%)
Held by Institutions 14.8 (%)
Shares Short 1,290 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.253e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 670.1 %
Return on Equity (ttm) -46.8 %
Qtrly Rev. Growth 1.09e+006 %
Gross Profit (p.s.) 0.04
Sales Per Share 0.07
EBITDA (p.s.) -0.69
Qtrly Earnings Growth -1 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -11 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 12.37
Price to Cash Flow -4.81
Stock Dividends
Dividend 0
Forward Dividend 286740
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android